Search

Search Constraints

You searched for: Author/Creator Gil, Nuria

Search Results

1. "First-In-Human" Clinical Trial Employing Adoptive Transfer of Autologous Thymus-Derived Treg Cells (thyTreg) to Prevent Graft Rejection in Heart-Transplanted Children. (July 2018)

2. "FIRST-IN-HUMAN" CLINICAL TRIAL EMPLOYING ADOPTIVE TRANSFER OF AUTOLOGOUS THYMUS-DERIVED TREG CELLS (THYTREG) TO PREVENT GRAFT REJECTION IN HEART-TRANSPLANTED CHILDREN. Issue 3 (September 2020)

3. 213.2: Preliminary Results of the First Clinical Trial to Prevent Graft Rejection in Heart Transplant Children Employing a Cellular Therapy With Autologous Treg Obtained From Thymic Tissue (thyTreg). (13th September 2022)

4. 213.2: Preliminary Results of the First Clinical Trial to Prevent Graft Rejection in Heart Transplant Children Employing a Cellular Therapy With Autologous Treg Obtained From Thymic Tissue (thyTreg). (13th September 2022)

5. Immune dysregulation and Th2 polarization are associated with atopic dermatitis in heart‐transplant children: A delicate balance between risk of rejection or atopic symptoms. Issue 5 (25th January 2019)

6. Impact of mechanical circulatory support on survival in pediatric heart transplantation. (25th March 2020)

7. Induction Therapy With Basiliximab in Heart-Transplanted Children Impairs Regulatory T-Cell Population (Treg): effects on frequency, phenotype and Foxp3 expression. (May 2017)

8. Th1/Th2 Imbalance and Early Age to Transplantation is Associated to Atopic Dermatitis in Heart-Transplanted Pediatric Patients. (July 2018)

9. The Presence of a Marked Imbalance Between Regulatory T Cells and Effector T Cells Reveals That Tolerance Mechanisms Could Be Compromised in Heart Transplant Children. Issue 5 (23rd April 2021)